Mucosal Vaccines: An Overview

Mucosal Immunology: Fourth Edition

Volumn 1-2, Issue , 2015, Pages 1039-1046

  Russell, Michael W ^a   Mestecky, Jiri ^b,c  

^a UNIVERSITY AT BUFFALO   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c INSTITUTE OF MICROBIOLOGY   (Czech Republic)

Author keywords

Adjuvants; Bacterial infections; Delivery systems; Mucosal tolerance; Mucosal vaccines; Passive immunization; Systemic vaccines; Vectors; Veterinary infections; Viral infections

Indexed keywords

EID: 84939558199     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-415847-4.00055-0     Document Type: Chapter

References (35)

1. Alley C.D., Nash G.S., MacDermott R.P. Marked in vitro spontaneous secretion of IgA by human rib bone marrow mononuclear cells. J. Immunol. 1982, 128:2604-2608.
2. Black C.A., Rohan L.C., Cost M., Watkins S.C., Draviam R., Alber S., Edwards R.P. Vaginal mucosa serves as an inductive site for tolerance. J. Immunol. 2000, 165:5077-5083.
3. Brandtzaeg P. The secretory immune system of lactating human mammary glands compared with other exocrine organs. Ann. N. Y. Acad. Sci. 1983, 409:353-381.
4. Brandtzaeg P., Kiyono H., Pabst R., Russell M.W. Terminology: nomenclature of mucosa-associated lymphoid tissue. Mucosal Immunol. 2008, 1:31-37.
5. Chase M.W. Inhibition of experimental drug allergy by prior feeding of the sensitizing agent. Proc. Soc. Exp. Biol. Med. 1946, 61:257-259.
6. Clemens J.D., Sack D.A., Harris J.R., Van Loon F., Chakraborty J., Ahmed F., Rao M.R., Khan M.R., Yunus M., Huda N., Stanton B.F., Kay E., Eeckels R., Walter S., Svennerholm A.M., Holmgren J. Field trial of oral cholera vaccines in Bangladesh: results from three-year follow-up. Lancet 1990, 335:270-273.
7. Crowley-Nowick P.A., Bell M.C., Brockwell R., Edwards R.P., Chen S., Partridge E.E., Mestecky J. Rectal immunization for induction of specific antibody in the genital tract of women. J. Clin. Immunol. 1997, 17:370-379.
8. Czerkinsky C., Cuburu N., Kweon M.N., Anjuere F., Holmgren J. Sublingual vaccination. Hum. Vaccines 2011, 7:110-114.
9. Elson C.O., Ealding W. Cholera toxin feeding did not induce oral tolerance in mice and abrogated oral tolerance to an unrelated protein antigen. J. Immunol. 1984, 133:2892-2897.
10. Hapfelmeier S., Lawson M.A., Slack E., Kirundi J.K., Stoel M., Heikenwalder M., Cahenzli J., Velykoredko Y., Balmer M.L., Endt K., Geuking M.B., Curtiss R., McCoy K.D., Macpherson A.J. Reversible microbial colonization of germ-free mice reveals the dynamics of IgA immune responses. Science 2010, 328:1705-1709.
11. Harrod T., Martin M., Russell M.W. Long-term persistence and recall of immune responses in aged mice after mucosal immunization. Oral Microbiol. Immunol. 2001, 16:170-177.
12. Husby S., Mestecky J., Moldoveanu Z., Holland S., Elson C.O. Oral tolerance in humans. T cell but not B cell tolerance after antigen feeding. J. Immunol. 1994, 152:4663-4670.
13. Kantele A., Häkkinen M., Moldoveanu Z., Lu A., Savilahti E., Alvarez R.D., Michalek S., Mestecky J. Differences in immune responses induced by oral and rectal immunizations with Salmonella typhi Ty21a: Evidence for compartmentalization within the common mucosal immune system in humans. Infect. Immun. 1998, 66:5630-5635.
14. Kraus T.A., Toy L., Chan L., Childs J., Mayer L. Failure to induce oral tolerance to a soluble protein in patients with inflammatory bowel disease. Gastroenterology 2004, 126:1771-1778.
15. Kutteh W.A., Koopman W.H., Conley M.E., Egan M.L., Mestecky J. Production of predominantly polymeric IgA by human peripheral blood lymphocytes stimulated in vitro with mitogens. J. Exp. Med. 1980, 152:1424-1429.
16. Kutteh W.H., Kantele A., Moldoveanu Z., Crowley-Nowick P.A., Mestecky J. Induction of specific immune responses in the genital tract of women after oral or rectal immunization and rectal boosting with Salmonella typhi Ty21a vaccine. J. Reprod. Immunol. 2001, 52:61-75.
17. Ladjeva I., Peterman J.H., Mestecky J. IgA subclasses of human colostral antibodies specific for microbial and food antigens. Clin. Exp. Immunol. 1989, 78:85-90.
18. Lavelle E.C., Grant G., Pusztai A., Pfüller U., O'Hagan D.T. The identification of plant lectins with mucosal adjuvant activity. Immunology 2001, 102:77-86.
19. Luger E.O., Fokuhl V., Wegmann M., Abram M., Tillack K., Achatz G., Manz R.A., Worm M., Radbruch A., Renz H. Induction of long-lived allergen-specific plasma cells by mucosal allergen challenge. J. Allergy Clin. Immunol. 2009, 124:819-826.
20. Lycke N., Holmgren J. Intestinal mucosal memory and presence of memory cells in lamina propria and Peyer's patches in mice 2years after oral immunization with cholera toxin. Scand. J. Immunol. 1986, 23:611-616.
21. Mei H.E., Yoshida T., Sime W., Hiepe F., Thiele K., Manz R.A., Radbruch A., Dörner T. Blood-borne human plasma cells in steady state are derived from mucosal immune responses. Blood 2009, 113:2461-2469.
22. Mestecky J. The common mucosal immune system and current strategies for induction of immune response in external secretions. J. Clin. Immunol. 1987, 7:265-276.
23. Mestecky J., McGhee J.R., Arnold R.R., Michalek S.M., Prince S.J., Babb J.L. Selective induction of an immune response in human external secretions by ingestion of bacterial antigen. J. Clin. Invest. 1978, 61:731-737.
24. Mestecky J., Russell M.W., Elson C.O. Perspectives on mucosal vaccines: is oral tolerance a barrier?. J. Immunol. 2007, 179:5633-5638.
25. Moldoveanu Z., Oliver F., Mestecky J., Elson C.O. Oral tolerance in humans: failure to suppress an existing immune response by oral antigen administration. Ann. N. Y. Acad. Sci. 2004, 1029:299-309.
26. Mutsch M., Zhou W., Rhodes P., Bopp M., Chen R.T., Linder T., Spyr C., Steffen R. Use of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland. New. Engl. J. Med. 2004, 350:896-903.
27. Ogra P.L. Effect of tonsillectomy and adenoidectomy on nasopharyngeal antibody response to poliovirus. New. Engl. J. Med. 1971, 284:59-64.
28. Ogra P.L., Karzon D.T., Righthand F., MacGillivray M. Immunoglobulin response in serum and secretions after immunization with live and inactivated poliovaccine and natural infection. New. Engl. J. Med. 1968, 279:893-900.
29. Phipps P.A., Stanford M.R., Sun J.B., Xiao B.G., Holmgren J., Shinnick T., Hasan A., Mizushima Y., Lehner T. Prevention of mucosally induced uveitis with a HSP60-derived peptide linked to cholera toxin B subunit. Eur. J. Immunol. 2003, 33:224-232.
30. Quiding-Järbrink M., Granström G., Nordström I., Holmgren J., Czerkinsky C. Induction of compartmentalized B-cell responses in human tonsils. Infect. Immun. 1995, 63:853-857.
31. Robbins J.B., Schneerson R., Szu S.C. Perspective: hypothesis: serum IgG antibody is sufficient to confer protection against infectious diseases by inactivating the inoculum. J. Infect. Dis. 1995, 171:1387-1398.
32. Sun J.-B., Raghavan S., Sjöling Å., Lundin S., Holmgren J. Oral tolerance induction with antigen conjugated to cholera toxin B subunit generates both Foxp3+CD25+ and Foxp3-CD25- CD4+ regulatory T cells. J. Immunol. 2006, 177:7634-7644.
33. Sun J.B., Holmgren J., Czerkinsky C. Cholera toxin B subunit: an efficient transmucosal carrier-delivery system for induction of peripheral immunological tolerance. Proc. Natl. Acad. Sci. U.S.A. 1994, 91:10795-10799.
34. Sun J.B., Rask C., Olsson T., Holmgren J., Czerkinsky C. Treatment of experimental autoimmune encephalomyelitis by feeding myelin basic protein conjugated to cholera toxin B subunit. Proc. Natl. Acad. Sci. U.S.A. 1996, 93:7196-7201.
35. Waldo F.B., van den Wall Bake A.W.L., Mestecky J., Husby S. Suppression of the immune response by nasal immunization. Clin. Immunol. Immunopathol. 1994, 72:30-34.